PALI (PALI) Stock Price & Analysis
PALI (PALI) rose 0.00% to USD 1.95 as of July 25, 2026 at 04:18 UTC, according to Nexqual real-time market data.
PALI last closed at USD 1.95; the session ranged USD 1.9–2.05 on volume of 2,301,097 shares. Market capitalization is —, with a 52-week range of USD 0.53–2.86 (NCM). Source: Nexqual, July 25, 2026 at 04:18 UTC.
Key Statistics (as of July 25, 2026 at 04:18 UTC)
| Price | USD 1.95 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 1.95 |
| Open | USD 1.95 |
| Day Range | USD 1.9 – 2.05 |
| 52-Week Range | USD 0.53 – 2.86 |
| Volume | 2,301,097 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (PALI)
Nexqual's technical model rates PALI "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 04:18 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 51.62 (neutral) |
| vs SMA50 | Above (USD 1.91) |
| MACD | 0.01 (positive) |
From PALI's Latest SEC 10-K Filing (filed 2026-03-20)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ENSC | Ensysce Biosciences, Inc. | USD 0.26 | ▼ 7.96% |
| KPRX | Kiora Pharmaceuticals, Inc. | USD 2.55 | ▲ 0.79% |
| REVB | Revelation Biosciences, Inc. | USD 1.06 | ▼ 7.83% |
| QNRX | Quoin Pharmaceuticals, Ltd. | USD 4.28 | ▼ 2.17% |
| RNAZ | TransCode Therapeutics, Inc. | USD 5.93 | ▼ 29.4% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:18 UTC. This page is informational and not investment advice.